Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05967091
NA

Ryme Medical TLD Pilot Study

Sponsor: Ryme Medical, Inc.

View on ClinicalTrials.gov

Summary

Targeted lung denervation (TLD) with the Ryme Medical Lung Denervation System in patients with chronic obstructive pulmonary disease (COPD) - Ryme Medical TLD Pilot Study

Official title: Targeted Lung Denervation (TLD) With the Ryme Medical Lung Denervation System in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Ryme Medical TLD Pilot Study

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-03-06

Completion Date

2026-05

Last Updated

2025-08-13

Healthy Volunteers

No

Interventions

DEVICE

Targeted Lung Denervation

Targeted Lung Denervation (TLD) is a bronchoscopically guided, minimally invasive procedure using the Ryme Medical Lung Denervation System

Locations (7)

Melbourne Health - The Royal Melbourne Hospital

Melbourne, Australia

Macquarie University

Sydney, Australia

Karl Landsteiner Institute for Lung Research

Vienna, Austria

Rigshospitalet

Copenhagen, Denmark

Healthycore

Tbilisi, Georgia

University of Groningen Medical Center

Groningen, Netherlands

Royal Brompton

London, United Kingdom